C. Guérémy

发表

Circadian rhythm in the membrane of circulating human blood cells: microviscosity and number of benzodiazepine binding sites. A search for regulation by plasma ions, nucleosides, proteins or hormones.

J. Sulon, F. Lévi, Y. Touitou, 1987, Chronobiology international.

Partial purification and pharmacology of peripheral-type benzodiazepine receptors.

G. Le Fur, A. Uzan, F. Bégassat, 1987, Journal of receptor research.

Multiple benzodiazepine receptors: evidence of dissociation between anticonflict and anticonvulsant properties by PK 8165 and PK 9084 (two quinoline derivatives).

M. Héaulme, G. Le Fur, A. Uzan, 1981, Life sciences.

Biochemical evidence that 2-phenyl-4[2-(4-piperidinyl) ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptors

G. Fur, A. Uzan, C. Malgouris, 1984, Neuropharmacology.

Pharmacological evidence that PK 8165 behaves as a partial agonist of brain type benzodiazepine receptors.

A. Uzan, C. Renault, M. Dubroeucq, 1984, Archives internationales de pharmacodynamie et de therapie.

Naphthosultam derivatives: a new class of potent and selective 5-HT2 antagonists.

C. Gueremy, A. Doble, J. Malleron, 1991, Journal of medicinal chemistry.

Histidine modification with diethylpyrocarbonate induces a decrease in the binding of an antagonist, PK 11195, but not of an agonist, RO5-4864, of the peripheral benzodiazepine receptors.

J. Bénavidès, G. Le Fur, A. Uzan, 1984, Life sciences.

Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: Anatomical and subcellular distribution

A. Basbaum, G. Fur, A. Uzan, 1987, Brain Research Bulletin.

Opposite effects of an agonist, RO5-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice.

G. Le Fur, A. Uzan, C. Renault, 1984, Life sciences.

Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies.

G. Le Fur, A. Uzan, F. Imbault, 1983, Life sciences.

Characterization of solubilized "peripheral type" benzodiazepine binding sites from rat adrenals by using [3H]PK 11195, an isoquinoline carboxamide derivative.

G. Le Fur, A. Uzan, C. Renault, 1985, Biochemical pharmacology.

Photoaffinity labeling of peripheral-type benzodiazepine-binding sites.

G. Le Fur, A. Uzan, C. Renault, 1987, Molecular pharmacology.

Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with [3H]PK 11195

M. Desban, J. Bénavidès, G. Fur, 1984, Brain Research Bulletin.

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—I Anticonvulsant properties

B. Meldrum, M. Croucher, A. Uzan, 1985, Neuropharmacology.

Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies.

J. Bénavidès, G. Le Fur, A. Uzan, 1983, Life sciences.

Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative.

A. Uzan, C. Renault, M. Dubroeucq, 1986, European journal of pharmacology.

Electrophysiological and pharmacological evidence that peripheral type benzodiazepine receptors are coupled to calcium channels in the heart.

G. Le Fur, A. Uzan, C. Renault, 1985, Life sciences.

Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in a guinea pig heart preparation.

G. Le Fur, A. Uzan, C. Renault, 1984, Life sciences.

Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination.

J. Bénavidès, G. Le Fur, A. Uzan, 1985, European journal of pharmacology.

Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies.

J. Bénavidès, P. Rufat, G. Le Fur, 1983, Life sciences.

Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization

G. Fur, A. Uzan, C. Malgouris, 1983, Journal of neurochemistry.

PK 11195, an antagonist of peripheral benzodiazepine receptors, reduces ventricular arrhythmias during myocardial ischemia and reperfusion in the dog.

G. Fur, G. Bouétard, G. Le Fur, 1985, European journal of pharmacology.

In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites.

J. Bénavidès, G. Fur, P. Rufat, 1984, European journal of pharmacology.

Quantitative Autoradiography of [3H]Indalpine Binding Sites in the Rat Brain: I. Pharmacological Characterization

H. Savaki, G. Le Fur, A. Uzan, 1985, Journal of neurochemistry.

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—II Biochemical properties

J. Bénavidès, A. Uzan, C. Gueremy, 1985, Neuropharmacology.

Pharmacological characterization of RP 62203, a novel 5‐hydroxytryptamine 5‐HT2 receptor antagonist

D. Girdlestone, A. Dupuy, C. Gueremy, 1992, British journal of pharmacology.

Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines.

S. Mignani, P. Hubert, J. Stutzmann, 1999, Journal of medicinal chemistry.

Pharmacology of peripheral type benzodiazepine receptors in the heart.

G. Le Fur, A. Uzan, C. Renault, 1985, Progress in clinical and biological research.

Opposite effects of two ligands for peripheral type benzodiazepine binding sites, PK 11195 and RO5-4864, in a conflict situation in the rat.

G. Le Fur, A. Uzan, C. Renault, 1985, Life sciences.

3-(4-Piperidinylalkyl)indoles, selective inhibitors of neuronal 5-hydroxytryptamine uptake.

G. Le Fur, A. Uzan, C. Gueremy, 1980, Journal of medicinal chemistry.